WASHINGTON, D.C.—Prostate cancer gene 3 (PCA3) may be a valuable predictor of pathologically confirmed low volume disease and insignificant prostate cancer (PCa), according to a study presented at the 2011 annual meeting of the American Urological Association.
WASHINGTON, D.C.—The rate of office-based PSA testing by primary care providers (PCPs) in the United States doubled from 1997 to 2008, according to data presented at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—Obese men are less likely to have an abnormal digital rectal examination (DRE) than non-obese men, according to findings presented at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—Prostate cancer (PCa) patients found to have extracapsular extension after radical prostatectomy have a greater risk of biochemical recurrence (BCR) recurrence 10 years after surgery, researchers reported at the American Urological Associatoin 2011 annual meeting.
WASHINGTON, D.C.—Active surveillance for screen-detected localized prostate cancer (PCa) does not increase the risk of death from prostate cancer (PCa) relative to definitive local treatment, according to study findings presented at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—Robot-assisted radical prostatectomy (RARP) for localized prostate cancer (PCa) offers favorable intermediate- and long-term oncologic outcomes, researchers reported at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—African-American race and older age are risk factors for development of proteinuria in men who receive androgen deprivation therapy (ADT) for prostate cancer (PCa), according to data presented at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—The extent of pelvic lymph node dissection (PLND) significantly affects the likelihood of biochemical recurrence (BCR) in patients with organ-confined prostate cancer (PCa), researchers reported at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—Contrary to emerging evidence, a new study suggests that androgen deprivation therapy (ADT) does not increase the risk of cardiovascular mortality, according to data presented at the American Urological Association 2011 annual meeting.
WASHINGTON, D.C.—Although studies have suggested that men with diabetes mellitus (DM) are at lower risk of prostate cancer (PCa), new findings suggest that DM is associated with a significantly increased risk of aggressive prostate tumors, researchers reported at the American Urological Association 2011 annual meeting.
Please login or register first to view this content.
